Mitotic Block and Epigenetic Repression Underlie Neurodevelopmental Defects and Neurobehavioral Deficits in Congenital Heart Disease

George C. Gabriel,Hisato Yagi,Tuantuan Tan,Abha S. Bais,Benjamin J. Glennon,Margaret C. Stapleton,Lihua Huang,William T. Reynolds,Marla G. Shaffer,Madhavi Ganapathiraju,Dennis Simon,Ashok Panigrahy,Yijen L. Wu,Cecilia W. Lo
DOI: https://doi.org/10.1101/2023.11.05.565716
2024-02-26
Abstract:Poor neurodevelopment is often observed with congenital heart disease (CHD), especially with mutations in chromatin modifiers. Here analysis of mice with hypoplastic left heart syndrome (HLHS) arising from mutations in Sin3A associated chromatin modifier , and adhesion protein revealed neurodevelopmental and neurobehavioral deficits reminiscent of those in HLHS patients. Microcephaly was associated with impaired cortical neurogenesis, mitotic block, and increased apoptosis. Transcriptional profiling indicated dysregulated neurogenesis by REST, altered CREB signaling regulating memory and synaptic plasticity, and impaired neurovascular coupling modulating cerebral blood flow. Many neurodevelopmental/neurobehavioral disease pathways were recovered, including autism and cognitive impairment. These same pathways emerged from genome-wide DNA methylation and Sap130 chromatin immunoprecipitation sequencing analyses, suggesting epigenetic perturbation. Mice with mutation or forebrain-specific deletion without CHD showed learning/memory deficits and autism-like behavior. These novel findings provide mechanistic insights indicating the adverse neurodevelopment in HLHS may involve cell autonomous/nonautonomous defects and epigenetic dysregulation and suggest new avenues for therapy.
Developmental Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the underlying mechanisms of neurodevelopmental deficits and neurobehavioral disorders observed in patients with congenital heart disease (CHD), especially hypoplastic left heart syndrome (HLHS). Specifically, the study focused on neurodevelopmental problems associated with mutations in chromatin modifiers, which may lead to neural genesis disorders, cell - cycle arrest, increased apoptosis, and abnormal epigenetic regulation. ### Research Background - **Congenital Heart Disease (CHD)**: Affects approximately 1% of live - born infants. With the progress of surgical operations, many CHD patients can survive into adulthood, but they are often accompanied by neurodevelopmental disorders, such as learning disabilities, impaired social/communication skills, and autism spectrum disorders. - **Hypoplastic Left Heart Syndrome (HLHS)**: It is a severe form of CHD. Patients are often accompanied by neurodevelopmental retardation and cognitive dysfunction, and abnormal brain development, such as microcephaly and holoprosencephaly, can be observed even in the fetal period. ### Research Objectives - **Explore the internal causes of neurodevelopmental disorders**: In addition to hypoxic injury and complications of multiple cardiac surgeries, the study also focuses on the internal factors of patients, especially genetic factors. - **Reveal specific mechanisms**: By analyzing mouse models carrying specific gene mutations (such as Sap130 and Pcdha9), study the molecular and cellular mechanisms of neurodevelopmental deficits. - **Explore new treatment approaches**: Provide new treatment ideas, especially targeted therapies for early intervention. ### Main Findings - **Neural genesis disorder**: A decrease in the generation of cortical neurons was observed in the mouse model, especially a reduction in the number of intermediate progenitor cells, resulting in a shortage of later - born neurons (such as layers II - IV). - **Cell - cycle arrest**: Mitotic arrest occurs during cell division, leading to the loss of neural precursor cells. - **Abnormal epigenetic regulation**: DNA methylation and Sap130 chromatin immunoprecipitation sequencing analysis show that abnormal epigenetic regulation may be involved in the mechanism of neurodevelopmental disorders. - **Neurovascular coupling defect**: Defects in the nitric oxide (NO) signaling pathway may lead to abnormal neurovascular coupling, which in turn affects cerebral blood flow regulation. ### Conclusion This study provides new mechanistic insights, indicating that neurodevelopmental disorders in HLHS patients may involve cell - autonomous and non - autonomous defects, as well as epigenetic regulation disorders. These findings provide a theoretical basis for the development of early intervention strategies for CHD patients.